Journal of the American Medical Association · 1958 · 39 citations · 9 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyNeuropharmacologyAnticholinergic ToxicityEnzyme InhibitionAnticholinergic DrugsAnticholinergic Toxicity ManagementOxime Antidotes
Intoxication by anticholinesterase compounds may occur in normal subjects after accidental exposure to organophosphorus insecticides (e. g., parathion<sup>1</sup>and tetraethylpyrophosphate [TEPP]<sup>2</sup>) and chemical warfare agents (e. g., sarin, one of the "nerve gases," isopropyl methyl phosphonofluoridate<sup>3</sup>). Similar intoxication may occur as a result of overtreatment of patients with myasthenia gravis with anticholinesterase medication, whether organophosphorus (TEPP or octamethyl pyrophosphoramide [OMPA]) or quaternary ammonium (neostigmine [Prostigmin], bis-neostigmine [BC-40], pyridostigmine [Mestinon], bis-pyridostigmine [hexamarium, BC-51], or ambenomium [Mytelase] ).<sup>4</sup>These compounds inhibit cholinesterase enzymes throughout the body, resulting in local accumulation of acetylcholine, which produces increased activity of smooth muscle and secretory glands ( manifested by nausea, vomiting, diarrhea, sweating, and increased salivary and bronchial secretion), bradycardia, central nervous system symptoms, muscular weakness, and fasciculations in normal subjects,<sup>3</sup>and increased strength which may be followed by weakness in patients with myasthenia gravis.<sup>4a</sup>In the management of the latter disease,
9